Table 5 Evaluation of outcomes of patients diagnosed with AIS using the modified Rankin scale (mRS).
mRS | Sex | Total n (%) | P value | |
|---|---|---|---|---|
Male n (%) | Female n (%) | |||
mRS at day 1 | ||||
1 | 9 (2.5) | 7 (3.0) | 16 (2.7) | |
2 | 40 (11.2) | 36 (15.3) | 76 (12.8) | |
3 | 137 (38.4) | 83 (35.3) | 220 (37.2) | |
4 | 151 (42.3) | 88 (37.4) | 239 (40.4) | 0.230 |
5 | 18 (5.0) | 16 (6.8) | 34 (5.7) | |
6 | 2 (0.6) | 5 (2.1) | 7 (1.2) | |
Missing | 1 | 0 | 1 | |
mRS at day 30* | ||||
0 | 8 (8.0) | 2 (4.5) | 10 (6.9) | |
1 | 21 (21.0) | 7 (15.9) | 28 (19.4) | |
2 | 29 (29.0) | 11 (25.0) | 40 (27.8) | |
3 | 22 (22.0) | 14 (31.8) | 36 (25.0) | 0.824 |
4 | 14 (14.0) | 7 (15.9) | 21 (14.6) | |
5 | 5 (5.0) | 2 (4.5) | 7 (4.9) | |
6 | 1 (1.0) | 1 (2.3) | 2 (1.4) | |
Missing | 258 | 191 | 449 | |
